New York, April 22 (IANS) Hydroxychloroquine, an anti-malarial drug termed potential "game changer" for COVID-19 by US President Donald Trump, showed no benefit in treating patients with the disease in Veterans Health Administration medical centres in the US, says a study.

1 / 1
Add your comments

Be the first to add a comment.


Latest News

Latest Photos